EMA — authorised 16 January 2014
- Marketing authorisation holder: VIIV HEALTHCARE BV
- Status: approved
EMA authorised Tivicay on 16 January 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 16 January 2014.
VIIV HEALTHCARE BV holds the EU marketing authorisation.